Figure 1 |
Evolution of Biomaterials |
Figure 2 |
Global Biomaterials Market Snapshot, 2016-2021 |
Figure 3 |
Global Biomaterials Market Share and Size, by Type, 2017 and 2021 |
Figure 4 |
Global Biomaterials Market Share, by Application: 2017 & 2021 |
Figure 5 |
Global Biomaterials Market, by Region, 2017 and 2021 |
Figure 6 |
Global Biomaterials Market, by Country, 2016 and 2021 |
Figure 1.1 |
Global Biomaterials Market Scope |
Figure 1.2 |
Report Design |
Figure 1.3 |
Sources of Secondary Research |
Figure 1.4 |
Data Triangulation |
Figure 1.5 |
Top Down & Bottom Up Approach |
Figure 2.1 |
Global Biomaterials Market Dynamics |
Figure 2.2 |
Number of Plastic Surgery Procedures and Percentage Share, by Country, 2014 |
Figure 2.3 |
Number of Plastic Surgery Procedures in the U.S., by Type, 2015 |
Figure 2.4 |
Global Percentage of Aging Population |
Figure 2.5 |
Global Percentage of Aging Population |
Figure 2.6 |
Cardiovascular Disease Death Rates, By Country, 2014 |
Figure 2.7 |
Key Facts about Joint Replacement (2014-2015) |
Figure 2.8 |
Global Medical Implants, by Application |
Figure 2.9 |
Medical Implants in the Human Body |
Figure 2.10 |
Key Trends in the Biomaterials Market |
Figure 3.1 |
Global Biomaterials Market Opportunity Matrix, by Region, 2016 |
Figure 3.2 |
Global Biomaterials Market Opportunity Matrix, by Country, 2016 |
Figure 3.3 |
Global Biomaterials Market Opportunity Matrix, by Country, 2021 |
Figure 3.4 |
Country Share Analysis of Global Biomaterials Market, 2016 |
Figure 3.5 |
R&D Focus Areas of Axio Bio |
Figure 3.6 |
R&D Analysis of Key Market Players |
Figure 3.7 |
Share of Key Market Strategies & Developments |
Figure 3.8 |
Total Number of Strategies & Developments |
Figure 4.1 |
Supply Chain Analysis of Biomaterials Market |
Figure 4.2 |
Biomaterial Science and a Path from a Need to Manufactured Medical Device |
Figure 4.3 |
Porter’s Five Forces Analysis of Biomaterials Market |
Figure 4.4 |
Future Trends and Developments in the Biomaterials Market |
Figure 5.1 |
Global Biomaterials Market Size, by Type, 2017 and 2021 |
Figure 5.2 |
Global Biomaterials Market, by Type, 2016-2021 |
Figure 5.3 |
Global Biomaterials Market Share, by Type, 2016-2021 |
Figure 5.4 |
Different Types of Biomaterials in Different Applications |
Figure 5.5 |
Global Metal based Biomaterials Market Size, (2016 – 2021) |
Figure 5.6 |
Evolution of Gold based Biomaterials in Medical Applications |
Figure 5.7 |
Application Overview of Gold |
Figure 5.8 |
Application Overview of Nitinol Based Biomaterials |
Figure 5.9 |
Alloy Composition of Nitinol |
Figure 5.10 |
Global Metal Based Biomaterials Market, by Region, 2016-2021 |
Figure 5.11 |
Global Polymer Based Biomaterials Market, 2017-2021 |
Figure 5.12 |
Polymer based Biomaterials Market, by Region, 2016-2021 |
Figure 5.13 |
Global Ceramic Based Biomaterials Market, 2017-2021 |
Figure 5.14 |
Ceramic Based Biomaterials Market, by Region, 2016-2021 |
Figure 5.15 |
Global Natural Biomaterials Market, 2017-2021 |
Figure 5.16 |
Collagen Biomaterials Market, by Region, 2016-2021 |
Figure 5.17 |
Properties of Inorganic Glass |
Figure 5.18 |
Inorganic Glass Based Biomaterials Market, by Region, 2016-2021 |
Figure 5.19 |
History of Calcium Phosphate Based Biomaterials |
Figure 5.20 |
Inorganic Based Biomaterials Market, by Region, 2016-2021 |
Figure 5.21 |
Global Radiopaque Biomaterials Market, 2017-2021 |
Figure 5.22 |
Radiopaque Biomaterials Market, by Region, 2016-2021 |
Figure 5.23 |
Regenerative Biomaterials Market, by Region, 2016-2021 |
Figure 5.24 |
Global Hybrid Biomaterial Combinations Market, 2017-2021 |
Figure 5.25 |
Hybrid Biomaterial Combinations Market, by Region, 2016-2021 |
Figure 6.1 |
Global Biomaterials Market, by Application |
Figure 6.2 |
Global Biomaterials Market, by Application, 2017 and 2021 |
Figure 6.3 |
Medical Devices and their Blood Contact Time |
Figure 6.4 |
Number of Procedures in Joint Construction, 2016 |
Figure 6.5 |
Global Ophthalmology Biomaterials Market, 2017-2021 |
Figure 6.6 |
Properties of Polymer Based Biomaterials in Ophthalmology |
Figure 6.7 |
Percent Share of Contact Lenses, by Region, 2014 |
Figure 6.8 |
Global Dental Biomaterials Market, (2016-2021) |
Figure 6.9 |
Key Facts and Figures on Dental Implantation in America |
Figure 6.10 |
Global Wound Healing Biomaterials Market, (2016 – 2021) |
Figure 6.11 |
Global Plastic Surgery Biomaterials Market, (2016 – 2021) |
Figure 6.12 |
Global Neurological/Central Nervous System Biomaterials Market, (2016 – 2021) |
Figure 6.13 |
Formation Engineered Tissue |
Figure 6.14 |
Global Tissue Engineering Biomaterials Market, (2016 – 2021) |
Figure 6.15 |
Properties of Biomaterial Scaffolds |
Figure 6.16 |
Global Other Applications Biomaterials Market, (2016 – 2021) |
Figure 7.1 |
Biomaterials Market Growth Rate, by Region |
Figure 7.2 |
Biomaterials Market Growth Rate, by Region, 2017 and 2021 |
Figure 7.3 |
North American Biomaterials Market Snapshot, 2016-2021 |
Figure 7.4 |
Factors Driving the Biomaterials Market in North American Biomaterials, 2017 and 2021 |
Figure 7.5 |
North American Distribution of Orthopedic Surgery Procedures, 2015 |
Figure 7.6 |
Surgical Procedures in North America, 2015 and 2016 |
Figure 7.7 |
Non-Surgical Procedures in North America, 2015 and 2016 |
Figure 7.8 |
The U.S. Biomaterials Market, by Application, 2017-2021 |
Figure 7.9 |
Increase in Plastic Surgeries in the U.S. from 2000 to 2015 |
Figure 7.10 |
Cancer Cases and Death Estimation in the U.S., 2017 |
Figure 7.11 |
Facts and Risks Associated with Cardiovascular Diseases in the U.S. |
Figure 7.12 |
Canadian Biomaterials Market, by Application, 2017-2021 |
Figure 7.13 |
Facts and Risks associated with Cardiovascular Diseases in the Canada |
Figure 7.14 |
Mexico Biomaterials Market, by Application, 2017-2021 |
Figure 7.15 |
Global European Biomaterials Market, 2017-2021 |
Figure 7.16 |
Factors Driving the Biomaterials Market in European Biomaterials, 2017 and 2021 |
Figure 7.17 |
Percent Share of different Kind of Diseases in Europe, by Male and Female, 2016 |
Figure 7.18 |
German Biomaterials Market, by Application, 2017-2021 |
Figure 7.19 |
The U.K. Biomaterials Market, by Application, 2017-2021 |
Figure 7.20 |
Common Plastic Surgery Procedure in the U.K. |
Figure 7.21 |
France Biomaterials Market, by Application, 2017-2021 |
Figure 7.22 |
Spain Biomaterials Market, by Application, 2017-2021 |
Figure 7.23 |
Italy Biomaterials Market, by Application, 2017-2021 |
Figure 7.24 |
Russia Biomaterials Market, by Application, 2017-2021 |
Figure 7.25 |
Rest of Europe Biomaterials Market, by Application, 2017-2021 |
Figure 7.26 |
Asia-Pacific Biomaterials Market Snapshot, 2016-2021 |
Figure 7.27 |
Factors Driving the Biomaterials Market in Asia-Pacific, 2017 and 2021 |
Figure 7.28 |
China Biomaterials Market, by Application, 2017-2021 |
Figure 7.29 |
Japan Biomaterials Market, by Application, 2017-2021 |
Figure 7.30 |
India Biomaterials Market, by Application, 2017-2021 |
Figure 7.31 |
Percentage of Heart Attack among Indians for Different Age Groups |
Figure 7.32 |
South Korean Biomaterials Market, by Application, 2017-2021 |
Figure 7.33 |
Indonesian Medical Device Regulation System |
Figure 7.34 |
Rest of Asia Pacific Biomaterials Market, by Application, 2017-2021 |
Figure 7.35 |
Middle East & Africa Biomaterials Market, 2017-2021 |
Figure 7.36 |
South American Biomaterials Market, by Type, 2017-2021 |
Figure 8.1 |
BASF SE: Overall Financials, 2014-2016 |
Figure 8.2 |
BASF SE: Geographic Revenue Mix, 2014-2016 |
Figure 8.3 |
BASF SE: Business Segment Revenue Mix, 2014-2016 |
Figure 8.4 |
Carpenter Technology Corporation: Overall Financials, 2014-2016 |
Figure 8.5 |
Carpenter Technology Corporation: Geographic Revenue Mix, 2014-2016 |
Figure 8.6 |
Carpenter Technology Corporation: Business Segment Revenue Mix, 2014-2016 |
Figure 8.7 |
Celanese Corporation: Overall Financials, 2014-2016 |
Figure 8.8 |
Celanese Corporation: Geographic Revenue Mix, 2014-2016 |
Figure 8.9 |
Celanese Corporation: Business Segment Revenue Mix, 2014-2016 |
Figure 8.10 |
Collagen Solutions: Overall Financials, 2014-2016 |
Figure 8.11 |
Collagen Solutions: Geographic Revenue Mix, 2014-2016 |
Figure 8.12 |
Corbion N.V.: Overall Financials, 2014-2016 |
Figure 8.13 |
Corbion N.V.: Geographic Revenue Mix, 2014-2016 |
Figure 8.14 |
Corbion N.V.: Business Segment Revenue Mix, 2014-2016 |
Figure 8.15 |
Corbion N.V.: Biochemical Sub-Segment Revenue Mix, 2014-2016 |
Figure 8.16 |
Covestro AG: Overall Financials, 2014-2016 |
Figure 8.17 |
Covestro AG: Geographic Revenue Mix, 2014-2016 |
Figure 8.18 |
Covestro AG: Business Segment Revenue Mix, 2014-2016 |
Figure 8.19 |
Koninklijke DSM N.V.: Overall Financials, 2014-2016 |
Figure 8.20 |
Koninklijke DSM N.V.: Geographic Revenue Mix, 2014-2016 |
Figure 8.21 |
Koninklijke DSM N.V.: Business Segment Revenue Mix, 2013-2015 |
Figure 8.22 |
Evonik Industries: Overall Financials, 2014-2016 |
Figure 8.23 |
Evonik Industries: Geographic Revenue Mix, 2014-2016 |
Figure 8.24 |
Evonik Industries: Business Segment Revenue Mix, 2014-2016 |
Figure 8.25 |
Zimmer Biomet Holdings Inc.: Overall Financials, 2014-2016 |
Figure 8.26 |
Zimmer Biomet Holdings Inc.: Geographic Revenue Mix, 2014-2016 |
Figure 8.27 |
Zimmer Biomet Holdings Inc.: Business Segment Revenue Mix, 2014-2016 |